Synapticure, a telemedicine company focused on neurodegenerative diseases, announced a partnership with the ALS Association to offer Synapticure's telemedicine platform as a supplement to in-person care. ALS Certified Treatment Center of Excellence and Certified Treatment Center.
Synapticure is a neurology-focused telemedicine company specializing in neurodegenerative diseases. We provide treatment for conditions such as Alzheimer's disease, Parkinson's disease, and ALS. It provides services such as mental health support, genetic testing, and guidance on clinical trials.
This partnership aims to address inequities in care for people with ALS who live in geographically remote areas where specialized care is often unavailable. He will also be made available as a point of contact for the ALS Association through Synapticure's virtual clinic to provide personalized support to patients.
“At Synapticure, our mission is focused on providing cutting-edge care regardless of geography. Our partnership with the ALS Association allows us to leverage our combined national reach and deep expertise. „Together, we will set a new standard for virtual care delivery.“ Co-founder Sandra Abrevaya said in a statement.
bigger trends
Synapticure launched It was founded in February 2022 with $6 million in seed funding led by venture capital investment arm GV. alphabet. Additional investment came from LifeForce Capital, Martin Ventures, Y-Combinator, and Byers Capital.
In September 2023, the Chicago-based company Joe Lineback appointed as new CEO. Mr. Leinbach was brought on as the company continues to expand its neurodegenerative disease products, which now include products for Alzheimer's disease and dementia.
December 2023, ALS Association partnered We are partnering with virtual respiratory care company NuvoAir to launch a program tailored to people living with ALS. The partnership was launched between his two clinics in Texas, the Texas Neurological Center and the University of Texas Health Science Center.
In February, the ALS Association received a $58 million donation from philanthropist Hugh Hoffman. This donation is aimed at advancing ALS treatment and developing his new ALS clinic.